A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Tetracosactide
Semaglutide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Semaglutide.
Tetracosactide
Guar gum
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Guar gum.
Tetracosactide
Remogliflozin etabonate
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Remogliflozin etabonate.
Tetracosactide
Balaglitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Balaglitazone.
Tetracosactide
Sotagliflozin
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Sotagliflozin.
Tetracosactide
2,4-thiazolidinedione
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with 2,4-thiazolidinedione.
Tetracosactide
Tofogliflozin
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Tofogliflozin.
Tetracosactide
Allicin
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Allicin.
Tetracosactide
Ipragliflozin
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Ipragliflozin.
Tetracosactide
Insulin beef
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Insulin beef.
Tetracosactide
Lixisenatide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Lixisenatide.
Tetracosactide
Ciglitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Ciglitazone.
Tetracosactide
Rivoglitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Rivoglitazone.
Tetracosactide
Netoglitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Netoglitazone.
Tetracosactide
Lobeglitazone
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Lobeglitazone.
Tetracosactide
Dulaglutide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Dulaglutide.
Tetracosactide
Albiglutide
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Albiglutide.
Tetracosactide
Benfluorex
The risk or severity of hypoglycemia can be increased when Linagliptin is combined with Benfluorex.
Tetracosactide
Liraglutide
The risk or severity of hypoglycemia can be increased when Liraglutide is combined with Linagliptin.
Tetracosactide
NBI-6024
The risk or severity of hypoglycemia can be increased when NBI-6024 is combined with Linagliptin.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3